These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12132587)

  • 1. Enzymatic characterization of glycosidase antibodies raised against a chair transition state analog and the retained catalytic activity from the expressed single chain antibody fragments.
    Choi SO; Youn HJ; Yu J
    Mol Cells; 2002 Jun; 13(3):463-9. PubMed ID: 12132587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and characterization of recombinant single-chain Fv and Fv fragments derived from a set of catalytic antibodies.
    Kim SH; Schindler DG; Lindner AB; Tawfik DS; Eshhar Z
    Mol Immunol; 1997; 34(12-13):891-906. PubMed ID: 9464525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A glycosidase antibody elicited against a chair-like transition state analog by in vitro immunization.
    Yu J; Choi SY; Moon KD; Chung HH; Youn HJ; Jeong S; Park H; Schultz PG
    Proc Natl Acad Sci U S A; 1998 Mar; 95(6):2880-4. PubMed ID: 9501184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Site-directed mutagenesis of active site contact residues in a hydrolytic abzyme: evidence for an essential histidine involved in transition state stabilization.
    Miyashita H; Hara T; Tanimura R; Fukuyama S; Cagnon C; Kohara A; Fujii I
    J Mol Biol; 1997 Apr; 267(5):1247-57. PubMed ID: 9150409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cloning and expression of a single-chain catalytic antibody that acts as a glutathione peroxidase mimic with high catalytic efficiency.
    Ren X; Gao S; You D; Huang H; Liu Z; Mu Y; Liu J; Zhang Y; Yan G; Luo G; Yang T; Shen J
    Biochem J; 2001 Oct; 359(Pt 2):369-74. PubMed ID: 11583583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro abzyme evolution to optimize antibody recognition for catalysis.
    Takahashi N; Kakinuma H; Liu L; Nishi Y; Fujii I
    Nat Biotechnol; 2001 Jun; 19(6):563-7. PubMed ID: 11385462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of hapten binding and catalytic determinants in a family of catalytic antibodies.
    Ulrich HD; Schultz PG
    J Mol Biol; 1998 Jan; 275(1):95-111. PubMed ID: 9451442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innate antibody catalysis.
    Gololobov G; Sun M; Paul S
    Mol Immunol; 1999 Dec; 36(18):1215-22. PubMed ID: 10684961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis for amide hydrolysis catalyzed by the 43C9 antibody.
    Thayer MM; Olender EH; Arvai AS; Koike CK; Canestrelli IL; Stewart JD; Benkovic SJ; Getzoff ED; Roberts VA
    J Mol Biol; 1999 Aug; 291(2):329-45. PubMed ID: 10438624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of a functional scFv fragment of an anti-idiotypic antibody with a beta-lactam hydrolytic activity.
    Padiolleau-Lefèvre S; Débat H; Phichith D; Thomas D; Friboulet A; Avalle B
    Immunol Lett; 2006 Feb; 103(1):39-44. PubMed ID: 16325271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conversion of an antibody into an enzyme which cleaves the protein HPr.
    Liu E; Prasad L; Delbaere LT; Waygood EB; Lee JS
    Mol Immunol; 1998 Nov; 35(16):1069-77. PubMed ID: 10068041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in the biochemical properties of esterolytic antibodies correlate with structural diversity.
    Zemel R; Schindler DG; Tawfik DS; Eshhar Z; Green BS
    Mol Immunol; 1994 Feb; 31(2):127-37. PubMed ID: 8309476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody catalysis of pericyclic reactions.
    Ulrich HD; Driggers EM; Schultz PG
    Acta Chem Scand (Cph); 1996 Apr; 50(4):328-32. PubMed ID: 8639375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constant domain-regulated antibody catalysis.
    Sapparapu G; Planque S; Mitsuda Y; McLean G; Nishiyama Y; Paul S
    J Biol Chem; 2012 Oct; 287(43):36096-104. PubMed ID: 22948159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystallographic and biochemical analysis of cocaine-degrading antibody 15A10.
    Larsen NA; de Prada P; Deng SX; Mittal A; Braskett M; Zhu X; Wilson IA; Landry DW
    Biochemistry; 2004 Jun; 43(25):8067-76. PubMed ID: 15209502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A common ancestry for multiple catalytic antibodies generated against a single transition-state analog.
    Miyashita H; Hara T; Tanimura R; Tanaka F; Kikuchi M; Fujii I
    Proc Natl Acad Sci U S A; 1994 Jun; 91(13):6045-9. PubMed ID: 8016113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzyme mimicry by the antiidiotypic antibody approach.
    Kolesnikov AV; Kozyr AV; Alexandrova ES; Koralewski F; Demin AV; Titov MI; Avalle B; Tramontano A; Paul S; Thomas D; Gabibov AG; Friboulet A
    Proc Natl Acad Sci U S A; 2000 Dec; 97(25):13526-31. PubMed ID: 11095704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Creation of a ribonuclease abzyme through site-directed mutagenesis.
    Fletcher MC; Kuderova A; Cygler M; Lee JS
    Nat Biotechnol; 1998 Nov; 16(11):1065-7. PubMed ID: 9831037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrabody construction and expression. II. A synthetic catalytic Fv fragment.
    Ohage EC; Wirtz P; Barnikow J; Steipe B
    J Mol Biol; 1999 Sep; 291(5):1129-34. PubMed ID: 10518948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted destruction of the HIV-1 coat protein gp41 by a catalytic antibody light chain.
    Hifumi E; Mitsuda Y; Ohara K; Uda T
    J Immunol Methods; 2002 Nov; 269(1-2):283-98. PubMed ID: 12379368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.